Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial.
Hideaki MiyakeYasumasa KakeiYuzo NakanoTomoaki TerakawaKeiko MiyakodaKenichi HaradaMasato FujisawaPublished in: BMJ open (2023)
jRCTs051220077.